Thomas Schöndorf

1.8k total citations
71 papers, 1.4k citations indexed

About

Thomas Schöndorf is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas Schöndorf has authored 71 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 19 papers in Oncology and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas Schöndorf's work include Diabetes Treatment and Management (11 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Metabolism, Diabetes, and Cancer (7 papers). Thomas Schöndorf is often cited by papers focused on Diabetes Treatment and Management (11 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Metabolism, Diabetes, and Cancer (7 papers). Thomas Schöndorf collaborates with scholars based in Germany, United States and Australia. Thomas Schöndorf's co-authors include Andreas Pfützner, Thomas Först, Martina Breidenbach, Daniel Rein, Christian M. Kurbacher, Uwe-Jochen Göhring, Peter Mallmann, Heike Engel, Torsten C. Schmidt and M Hanefeld and has published in prestigious journals such as Cell, Diabetes Care and PLANT PHYSIOLOGY.

In The Last Decade

Thomas Schöndorf

69 papers receiving 1.3k citations

Peers

Countries citing papers authored by Thomas Schöndorf

Since Specialization

Citations

This map shows the geographic impact of Thomas Schöndorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schöndorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schöndorf more than expected).

Fields of papers citing papers by Thomas Schöndorf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schöndorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schöndorf. The network helps show where Thomas Schöndorf may publish in the future.

Co-authorship network of co-authors of Thomas Schöndorf

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schöndorf. A scholar is included among the top collaborators of Thomas Schöndorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schöndorf. Thomas Schöndorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MitoRibo-Tag Mice Provide a Tool for In Vivo Studies of Mitoribosome Composition 2019 ·Cell Reports ·Jakob D. Busch, Miriam Cipullo, Ilian Atanassov, Ana Bratić, Eduardo Silva Ramos, Thomas Schöndorf, Xinping Li, Sarah F. Pearce, Dusanka Milenkovic, Joanna Rorbach, Nils‐Göran Larsson	27
2	Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer 2012 ·Oncology Letters ·Daniel Rein, Anne Kathrin Volkmer, Jens Volkmer, Ines Beyer, Wolfgang Janni, Markus C. Fleisch, (unknown), Dirk Bauerschlag, Thomas Schöndorf, Martina Breidenbach	10
3	PIOfix-Study: Effects of Pioglitazone/Metformin Fixed Combination in Comparison with a Combination of Metformin with Glimepiride on Diabetic Dyslipidemia 2011 ·Diabetes Technology & Therapeutics ·Andreas Pfützner, Thomas Schöndorf, Diethelm Tschöpe, Ralf Lobmann, Jürgen Merke, Jürgen Müller, Ute Lehmann, W Fuchs, Thomas Först	15
4	Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer 2011 ·Journal of Cancer Research and Clinical Oncology ·Daniel Rein, Anne Kathrin Volkmer, Gerd Bauerschmitz, Ines Beyer, Wolfgang Janni, Markus C. Fleisch, (unknown), Dirk Bauerschlag, Thomas Schöndorf, Martina Breidenbach	9
5	Hysteroscopic Management of Residual Trophoblastic Tissue Is Superior to Ultrasound-Guided Curettage 2011 ·Journal of Minimally Invasive Gynecology ·Daniel Rein, Torsten C. Schmidt, A.P. Hess, Anne Kathrin Volkmer, Thomas Schöndorf, Martina Breidenbach	97
6	Competact, a Fixed Combination of Pioglitazone and Metformin, Improves Metabolic Markers in Type 2 Diabetes Patients with Insufficient Glycemic Control by Metformin Alone—Results from a Post-Marketing Surveillance Trial Under Daily Routine Conditions 2009 ·Diabetes Technology & Therapeutics ·Thomas Schöndorf, Efstrathios Karagiannis, (unknown), Thomas Först, Andreas Pfützner	5
7	Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State 2008 ·Diabetes Care ·(unknown), Thomas Först, Martin Larbig, Michael Safinowski, (unknown), (unknown), Matthias M. Weber, Thomas Schöndorf, Andreas Pfützner	12
8	A new targeting approach for breast cancer gene therapy using the Heparanase promoter 2005 ·Cancer Letters ·Martina Breidenbach, Daniel Rein, Thomas Schöndorf, (unknown), (unknown), Torsten C. Schmidt, Paul N. Reynolds, Israël Vlodavsky, Yosef S. Haviv, David T. Curiel	17
9	Dysregulation of protein kinase C activity in chemoresistant metastatic breast cancer cells 2004 ·Anti-Cancer Drugs ·Thomas Schöndorf, Markus Hoopmann, Martina Breidenbach, Daniel Rein, Uwe-Jochen Göhring, Martina Becker, Peter Mallmann, Christian M. Kurbacher	6
10	PTEN mutations do not cause nuclear β-catenin accumulation in endometrial carcinomas 2004 ·Human Pathology ·Barbara Wappenschmidt, Eva Wardelmann, Andrea Gehrig, Thomas Schöndorf, Nicolaì Maass, G. Bonatz, A. M. Gassel, Torsten Pietsch, Peter Mallmann, Bernhard H. F. Weber, Rita K. Schmutzler	14
11	Hematological side-effect profiles of individualized chemotherapy regimen for recurrent ovarian cancer 2003 ·Anti-Cancer Drugs ·Martina Breidenbach, Daniel Rein, Thomas Schöndorf, Torsten C. Schmidt, (unknown), Markus M. Valter, Christian M. Kurbacher	18
12	Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis 2003 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Karla L. Roehrig, Thomas Schöndorf, Agata Lazar, Markus C. Fleisch, Dieter Niederacher, (unknown), Peter Dall	61
13	Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study 2002 ·Gynecologic Oncology ·Daniel Rein, Christian M. Kurbacher, Martina Breidenbach, Thomas Schöndorf, Torsten C. Schmidt, (unknown), Uwe-Jochen Göhring, Jens‐Uwe Blohmer, Peter Mallmann	20
14	Tumor M2 pyruvate kinase – determination in breast cancer patients receiving trastuzumab therapy 2002 ·Cancer Letters ·Markus Hoopmann, Mathias Warm, Peter Mallmann, Anke Thomas, Uwe-Jochen Göhring, Thomas Schöndorf	17
15	Ex vivo assays to evaluate the role of protein kinase C in tumor cells of patients with breast cancer. 2001 ·PubMed ·Thomas Schöndorf, Martina Becker, (unknown), Christian M. Kurbacher, Uwe-Jochen Göhring	2
16	p21waf correlates with DNA replication but not with prognosis in invasive breast cancer 2001 ·Journal of Clinical Pathology ·U.-J. Göhring, (unknown), Minerva Becker, (unknown), Thomas Schöndorf	32
17	Fetal Cord Blood as an Alternative Source of Hematopoietic Progenitor Cells: Immunophenotype, Maternal Cell Contamination, and Ex Vivo Expansion 1999 ·Journal of Hematotherapy ·Heike Engel, Ekrem Kaya, R. Bald, (unknown), (unknown), Thomas Schöndorf, (unknown), Christian M. Kurbacher, U.-J. Göhring, (unknown), Peter Mallmann	5
18	Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas 1999 ·Cancer Letters ·Thomas Schöndorf, Anton Scharl, Christian M. Kurbacher, (unknown), Martina Becker, Rainer Neumann, (unknown), (unknown), Peter Mallmann, Uwe-Jochen Göhring	12
19	Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients 1998 ·Journal of the Society for Gynecologic Investigation ·Thomas Schöndorf, Heike Engel, (unknown), (unknown), (unknown), U.-J. Göhring, Anton Scharl, Peter Mallmann	13
20	The Choice of Reducing Substrate Is Altered by Replacement of an Alanine by a Proline in the FAD Domain of a Bispecific NAD(P)H-Nitrate Reductase from Birch 1995 ·PLANT PHYSIOLOGY ·Thomas Schöndorf, Wolfgang Hachtel	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact